Rx-Strength Pepcid Could Join Prilosec OTC In Consumer Market
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson/Merck is preparing to introduce a prescription strength version of Pepcid (famotidine) for over-the-counter sale